The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
GN Store Nord A/S
SWB:GNN
|
DK |
|
X
|
Xtra Gold Resources Corp
OTC:XTGRF
|
BS |
|
Cullinan Therapeutics Inc
NASDAQ:CGEM
|
US |
|
Nanollose Ltd
ASX:NC6
|
AU |
|
Schindler Holding AG
SIX:SCHN
|
CH |
|
Esotiq & Henderson SA
F:K4Q
|
PL |
|
N
|
NC& Co Ltd
KOSDAQ:092600
|
KR |
|
Captor Therapeutics SA
F:60Q
|
PL |
|
G
|
Goldex Resources Corp
XTSX:GDX
|
CA |
|
Champion Iron Ltd
TSX:CIA
|
AU |
|
P
|
Palfinger AG
OTC:PLFRF
|
AT |
|
K
|
Kopin Corp
F:KOC
|
US |
|
Real Brands Inc
OTC:RLBD
|
US |
|
Expedia Group Inc
NASDAQ:EXPE
|
US |
|
F
|
Fresenius Medical Care AG & Co KGaA
F:FME
|
DE |
|
N
|
Northern Shield Resources Inc
OTC:NSHRF
|
CA |
|
G
|
Green Plains Inc
XMUN:G3V
|
US |
|
A
|
Albemarle Corp
SWB:AMC
|
US |
|
BTC Health Ltd
ASX:BTC
|
AU |
|
Alsea SAB de CV
BMV:ALSEA
|
MX |
|
Verimatrix SA
PAR:VMX
|
FR |
|
T
|
Toyota Tsusho Corp
TSE:8015
|
JP |
|
Citizens Bancshares Corp (South Carolina)
OTC:CITZ
|
US |
|
C
|
CCL Industries Inc
OTC:CCLLF
|
CA |
GN Store Nord A/S (GNN)’s 12-month stock price forecast through August 2027 has a consensus target of €15.42, implying 28% upside. The forecast is based on price targets from 17 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
GNN is 15.42 EUR with a low forecast of 10.69 EUR and a high forecast of 18.51 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 5 years is -5%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 5 years is -6%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 5 years is -3%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 5%. The projected CAGR for the next 3 years is -1%.
Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 3 years is 14%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more